Stocks
BridgeBio (BBIO) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 4 086% | 4 483% | 941.3% | 6 374% | 34 894% | 8 292% | |||
| Changes by years, y/y, % | +3 316pp | +397pp | -3 542pp | +5 433pp | +28 520pp | +114.4% | |||
BridgeBio. R&D/CAPEX, %
BridgeBio. R&D/CAPEX, changes, pp
BridgeBio (BBIO) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 29 034% | 29 937% | 9 449% | 4 687% | 6 954% | 8 292% | ||
| Changes by years, y/y, % | +16 845pp | +18 508pp | -769 818pp | -20 567pp | -22 080pp | |||
| Changes by quarters, q/q, % | +3 780pp | +903pp | -20 488pp | -4 761pp | +2 267pp | |||
